Georgetown University MS Tumor Biology

What is Georgetown MS Tumor Biology?

The full-time MS Tumor Biology runs 10 months, requires 30 credits and focuses on cancer biology, tumour mechanisms and interdisciplinary laboratory experience. Georgetown’s official programme page defines that route. The Indian planning total is INR 95.13 lakh at the stated conversion basis.

The academic sequence moves from Cancer Biology through Molecular Oncology and Tumor Immunology toward Laboratory Experience, where research communication becomes assessed evidence. This record covers the full-time in-person route only. Admission, funding, professional licensing, employment and immigration remain separate decisions.

How much does Georgetown MS Tumor Biology cost for an Indian student?

The full-route estimate is USD 98,466, about INR 95.13 lakh. It uses Georgetown’s 2026-27 published cost basis, then adds the USD 90 application, USD 350 SEVIS and USD 185 F-1 visa fees where they are outside the institutional budget.

Housing deposits, licensing or bar-exam costs, equipment and exchange spread remain outside this estimate. USD 1 = INR 96.6149, from ECB reference rates checked on 22 October 2026.

The first line uses Georgetown’s 2026-27 published basis for this route: USD 67,671. The institution may revise rates before enrolment, and extra credits or additional terms can raise the final bill.

The non-tuition model is USD 30,170 across the stated 10 months route. It follows the applicable Georgetown cost-of-attendance categories for housing, food, books, personal spending and transport rather than assuming part-time earnings.

The setup line contains the USD 90 graduate application payment, USD 350 SEVIS I-901 fee and USD 185 F-1 visa application fee. Air travel, housing deposits, professional examinations, equipment and foreign-exchange spread remain outside the total.

Can an Indian graduate meet Georgetown MS Tumor Biology entry requirements?

Conditionally. The programme requires a recognised bachelor’s degree with biology, biochemistry or related biomedical preparation. Georgetown then applies its international graduate rules and programme-specific selection. Meeting a published floor is eligibility evidence, not an admission prediction. The review also tests how that preparation supports the intended course sequence.

For MS Tumor Biology, the research note should make cancer-mechanism analysis concrete before the file claims readiness for Cancer Biology. A module title doesn’t prove that capability; a result, method and limitation show how the applicant actually used cancer-mechanism analysis. The statement can then explain why Molecular Oncology must add molecular oncology reasoning now.

The application should keep three jobs separate. Transcripts establish preparation for Cancer Biology; referees verify observed laboratory technique; the statement connects both to the Laboratory Experience component. That chain is more persuasive for MS Tumor Biology than a generic account of Georgetown, Washington, DC or the degree’s prestige.

A document map for MS Tumor Biology can be literal: mark the transcript line that supports Cancer Biology, attach the work sample that demonstrates cancer-mechanism analysis, and ask a referee to verify the decision behind laboratory technique. The statement should then identify why Cancer Research Methods is necessary before the applicant attempts Laboratory Experience. That order makes missing preparation visible early.

Four boundaries in the admission decision

1. A minimum is not an offer

   Programme fit, faculty capacity, references and the full applicant pool still affect selection.

2. Cancer-Mechanism Analysis needs evidence

   A named course, project or research result is stronger than a broad degree label for proving cancer-mechanism analysis.

3. Research or portfolio fit is specific

   The application should connect the applicant’s record to the Laboratory Experience requirement.

4. Work rights are separate

   Admission does not settle visa issuance, OPT, employment, sponsorship or permanent residence.

How should an Indian student apply for Georgetown MS Tumor Biology?

The official application point is 1 July 2027 final deadline. Start with the live programme checklist, then submit the complete academic, programme and international file before that point. Every required item must arrive on time; the application payment does not repair a missing requirement after closure.

Establish programme fit, assemble the exact evidence, submit before 1 July 2027 final deadline, then complete offer and F-1 requirements.

The allowances are Nbyula planning estimates, not processing times published by Georgetown University.

Preparation begins with the exact MS Tumor Biology evidence chain. The transcript establishes academic history, the statement explains the intended work, and referees verify observed capability; none of those documents performs the job of another.

The application is complete only when programme-specific materials are present before 1 July 2027 final deadline. A later official transcript or offer condition is different from omitting an item required for review.

After an offer, the university’s acceptance, proof-of-funding and I-20 process precede the separate SEVIS payment and visa application. Admission itself is not an immigration decision.

International applicants should not submit supporting financial and sponsorship documentation during the initial application process, but should instead wait until after an official offer of admission has been made.Georgetown graduate application information

What can Georgetown MS Tumor Biology lead to?

The curriculum can support evidence for cancer research associate, oncology laboratory scientist and biotechnology analyst directions, but these are not placement predictions. An applicant still has to meet employer or regulator standards. USCIS OPT rules govern conditional work authorisation; licensing, bar admission, hiring and sponsorship remain separate.

These are curriculum-linked directions, not measured probabilities of employment, salary, sponsorship, licensing or permanent residence.

Evidence for a cancer research associate direction can come from Cancer Biology, provided the record identifies the applicant’s own cancer-mechanism analysis decisions. Molecular Oncology serves a different purpose: it can support oncology laboratory scientist work by showing molecular oncology reasoning in a result that another reader can inspect.

The Tumor Immunology component may strengthen a biotechnology analyst case through laboratory technique, while Laboratory Experience can anchor discussion of doctoral researcher work through research communication. These aren’t measured job probabilities for MS Tumor Biology; employer standards, licensing and immigration still set independent thresholds.

A useful MS Tumor Biology work sample preserves four things: the question taken from Cancer Biology, the method strengthened through Molecular Oncology, the limitation uncovered in Tumor Immunology, and the final decision made during Laboratory Experience. That record lets a cancer research associate, oncology laboratory scientist or biotechnology analyst reviewer see contribution rather than infer it from the Georgetown degree title.

Who is Georgetown MS Tumor Biology for?

MS Tumor Biology fits an applicant who can show cancer-mechanism analysis, needs molecular oncology reasoning, accepts the Laboratory Experience component and can finance INR 95.13 lakh plus excluded costs. The strongest match can also explain why Molecular Oncology belongs in the intended next step.

The closest-fit applicant reaches Georgetown with evidence of cancer-mechanism analysis, a defined need for molecular oncology reasoning, and a reason to complete the Laboratory Experience component. Interest in Tumor Immunology is not enough if the applicant would avoid Cancer Research Methods or has no use for the work produced there.

A weaker fit wants the label of MS Tumor Biology but cannot connect Cancer Biology to a prior result or Molecular Oncology to a future task. Financial fit is separate: the INR 95.13 lakh model needs a reserve for excluded costs and can’t rest on uncertain US earnings.

The fit conversation should name the trade-off inside MS Tumor Biology. Time spent on Cancer Biology and Molecular Oncology is valuable for an applicant seeking molecular oncology reasoning; the same time is wasteful for someone who already demonstrates it. Likewise, Cancer Research Methods belongs in the plan only when the intended doctoral researcher direction can use the research communication evidence produced through Laboratory Experience.

What does Georgetown MS Tumor Biology cover?

The official programme source sets out the 30-credit route summarised below. Its later components include Cancer Research Methods and Laboratory Experience. The rows distinguish named subjects, assessed work and the culminating requirement; they form an academic map, not a promise that every elective runs in every term.

The note “Named course, requirement or programme component” applies to 5 components in this table.

• Complete at least 30 approved graduate credits.
• Follow the full-time professionally oriented plan and its academic standing rules.
• Complete 30 credits including interdisciplinary tumour-biology study and laboratory experience.

Cancer Biology establishes one part of the programme’s method base, while Molecular Oncology develops the second. Their practical value depends on the actual assignment, approved research or project plan and the standard applied to the final work.

The degree culminates in 30 credits including interdisciplinary tumour-biology study and laboratory experience. Adviser capacity, elective availability, ethics approval, internship placement or production resources can affect the individual sequence where relevant.

Georgetown may revise course availability and sequencing before enrolment. The admitted student’s written plan and current catalog govern the final combination rather than an editorial sample assembled in advance.

Should an Indian student shortlist Georgetown MS Tumor Biology?

The practical test for MS Tumor Biology is whether earlier cancer-mechanism analysis work can progress through Molecular Oncology into the Laboratory Experience component. The INR 95.13 lakh plan only makes sense when that academic move and the financing plan are both credible.

A strong yes-case for MS Tumor Biology starts with inspectable cancer-mechanism analysis, adds the missing molecular oncology reasoning demanded by Molecular Oncology, and uses Laboratory Experience to preserve evidence of research communication. That sequence can support a later cancer research associate or oncology laboratory scientist application without turning either occupation into a promised result.

Reject this option when Cancer Biology repeats completed study, when Cancer Research Methods is outside the intended work, or when the applicant does not want the Laboratory Experience requirement. It is also the wrong financial choice if the INR 95.13 lakh estimate depends on a guaranteed cancer research associate salary, because Georgetown publishes no such guarantee.

Sources

These sources support the programme, admission, cost and immigration information used on this page.

Sources checked on October 22, 2026. Current intake information follows. Fall 2027 full-time intake.